Flexible SERS Biosensor Based on Core-Shell Nanotags for Sensitive and Multiple Detection of T1DM Biomarkers

Anal Chem. 2023 Sep 26;95(38):14203-14208. doi: 10.1021/acs.analchem.3c01791. Epub 2023 Sep 1.

Abstract

Sensitive and multiple detection of the biomarkers of type 1 diabetes mellitus (T1DM) is vital to the early diagnosis and clinical treatment of T1DM. Herein, we developed a SERS-based biosensor using polyvinylidene fluoride (PVDF) membranes as a flexible support for the detection of glutamic acid decarboxylase antibodies (GADA) and insulin autoantibodies (IAA). Two kinds of silver-gold core-shell nanotags embedded with Raman probes and attached with GADA or IAA antibodies were synthesized to capture the targets, enabling highly sensitive and highly selective detection of GADA and IAA. The embedded Raman probes sandwiched between silver and gold layers guaranteed spectral stability and reliability. Moreover, the utilization of two Raman probes enables simultaneous and multiplexing detection of both GADA and IAA, improving the detection accuracy for T1DM. The proposed SERS-based method has been proven feasible for clinical sample detection, demonstrating its great potential in sensitive, reliable, and rapid diagnosis of T1DM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies
  • Biomarkers
  • Biosensing Techniques*
  • Diabetes Mellitus, Type 1* / diagnosis
  • Gold
  • Humans
  • Metal Nanoparticles*
  • Reproducibility of Results
  • Silver
  • Spectrum Analysis, Raman / methods

Substances

  • Silver
  • Biomarkers
  • Antibodies
  • Gold